The increase in DNMT3A expression levels observed in the lesional tissues of the patients with AD and the elevated levels of DNMT1, DNMT3A, DNMT3L, and TET3 in the blood, compared to the controls, may be attributed to cellular stress resulting from inflammation associated with AD. The gene discussed is DNMT3A; the disease is Alzheimer disease.